Survival of AML patients relapsing after allogeneic hematopoietic cell transplantation: a CIBMTR study

Acute myeloid leukemia (AML) relapse after allogeneic hematopoietic cell transplantation (alloHCT) remains a major therapeutic challenge. We studied outcomes of 1788 AML patients relapsing after alloHCT (1990–2010) during first or second complete remission (CR) to identify factors associated with lo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biol Blood Marrow Transplant
Autori principali: Bejanyan, Nelli, Weisdorf, Daniel J., Logan, Brent R., Wang, Hai-Lin, Devine, Steven M., de Lima, Marcos, Bunjes, Donald W., Zhang, Mei-Jie
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4329076/
https://ncbi.nlm.nih.gov/pubmed/25460355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.11.007
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi